Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Morrens

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Acta Psychiatrica Scandinavica|February 25, 2012
Parsing the components of the psychomotor syndrome in schizophreniaL Docx, M Morrens, C Bervoets, et al.
Psychopharmacology|September 12, 2013
The nicotinergic receptor as a target for cognitive enhancement in schizophrenia: barking up the wrong tree?C Quisenaerts, M Morrens, W Hulstijn, et al.
Brain, Behavior, & Immunity - Health|October 1, 2024
Efficacy of inflammation-based stratification for add-on celecoxib or minocycline in major depressive disorder: Protocol of the INSTA-MD double-blind placebo-controlled randomised clinical trialC Wessa, J Janssens, V Coppens, et al.
Brain, Behavior, and Immunity|September 23, 2023
High unrecognized SARS-CoV-2 exposure of newly admitted and hospitalized psychiatric patientsK El Abdellati, A Lucas, H Perron, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Acta Psychiatrica Scandinavica|February 25, 2012
Parsing the components of the psychomotor syndrome in schizophreniaL Docx, M Morrens, C Bervoets, et al.
Psychopharmacology|September 12, 2013
The nicotinergic receptor as a target for cognitive enhancement in schizophrenia: barking up the wrong tree?C Quisenaerts, M Morrens, W Hulstijn, et al.
Brain, Behavior, & Immunity - Health|October 1, 2024
Efficacy of inflammation-based stratification for add-on celecoxib or minocycline in major depressive disorder: Protocol of the INSTA-MD double-blind placebo-controlled randomised clinical trialC Wessa, J Janssens, V Coppens, et al.
Brain, Behavior, and Immunity|September 23, 2023
High unrecognized SARS-CoV-2 exposure of newly admitted and hospitalized psychiatric patientsK El Abdellati, A Lucas, H Perron, et al.
Pageof 4